Effects of Experimental Hyperketonemia on Myocardial Metabolism
NCT02814474 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2016-07-04
Summary
Starvation and metabolic stress increase circulating ketone bodies, potentially providing the heart with an alternative oxidative fuel. Hyperketonemia reduces myocardial fatty acid consumption. It is unclear whether this is due to inhibited peripheral lipolysis or diminished uptake per se.
Aim: To test whether infusion of 3-hydroxybutyrate (BHB) inhibits myocardial glucose and fatty acid uptake.
Methods: Randomized, single blinded, cross-over interventional study in 8 healthy volunteers. Myocardial glucose and fatty acid metabolism studied by 11C-palmitate and 18F-FDG PET/CT. Experimental elevation of circulating ketone bodies by infusion of β-hydroxy-β-methylbutyrate.
Conditions
- Healthy Volunteers
Interventions
- OTHER
-
Na-3-hydroxybutyrate
Infusion of Na-3-hydroxybutyrate (0.18 g/kg/hour) for 390 minutes
- OTHER
-
Saline
Infusion of 0.9 % saline
Sponsors & Collaborators
-
Aarhus University Hospital
collaborator OTHER -
University of Aarhus
lead OTHER
Principal Investigators
-
Niels Møller, MD DMsc · Aarhus University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 50 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- Denmark
Study Locations
More Related Trials
-
Glucolipotoxicity and Type 2 Diabetes
NCT01375270 ·Status: COMPLETED ·Phase: NA
-
Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
NCT00264199 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Breath Acetone and Blood Beta-Hydroxybutyrate
NCT03299543 ·Status: COMPLETED
-
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
NCT00747968 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
NCT00418288 ·Status: COMPLETED ·Phase: NA
-
A Glucometabolic Evaluation of Patients With Idiopathic Ketotic Hypoglycemia
NCT05310292 ·Status: UNKNOWN ·Phase: NA
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
NCT03835013 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism
NCT04300049 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Metformin Treatment on Myocardial Efficiency in Patients With Heart Failure
NCT02810132 ·Status: COMPLETED ·Phase: PHASE2
-
Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients
NCT01374594 ·Status: COMPLETED
-
Glucagon Like Peptide-1 in Remote Ischemic Conditioning
NCT02746757 ·Status: COMPLETED ·Phase: NA
-
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
NCT04307797 ·Status: COMPLETED ·Phase: PHASE4
-
β-hydroxybutyrate, Glucose Metabolism and Prediabetes
NCT03889210 ·Status: COMPLETED ·Phase: NA
-
Peripheral Metabolic Effects of Ghrelin
NCT00771940 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
NCT00256256 ·Status: COMPLETED ·Phase: NA
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Acute Changes in Plasma Glucose and Cardiovascular Disease in Diabetes
NCT05500352 ·Status: UNKNOWN ·Phase: NA
-
The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 Diabetes
NCT06881472 ·Status: COMPLETED ·Phase: NA
-
Glucagon's Cardiovascular Effects With and Without Beta-blocker-induced Cardioinhibition
NCT03533179 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults
NCT02333591 ·Status: COMPLETED ·Phase: PHASE4
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
NCT01021865 ·Status: COMPLETED
-
Hyperglycemia and the Extra-pancreatic Effect of Incretins
NCT01749163 ·Status: COMPLETED ·Phase: NA